Tai Chi to Optimize Transplant Outcomes for Multiple Myeloma

Overview

About this study

The current proposal aims to test the feasibility of immune function analysis for Tai Chi Easy (TCE) intervention in multiple myeloma (MM) patients undergoing autologous stem cell transplantation (ASCT) with concurrent exploration of health related quality of life (HRQOL).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosis of Multiple Myeloma planned to undergo bone marrow transplant.
  • 18 years or older.
  • English speaking.
  • General proficiency to read/write in English.
  • Able to attend TCE training session per study protocol.
  • ECOG performance status 0-1.

Exclusion Criteria:

  • Currently performs Tai Chi, QiQong, or yoga at least once weekly or more.
  • Syncopal event in prior 60 days.
  • Concurrent major depressive disorder or anxiety disorder (DSMIV).
  • Chronic dizziness or vestibular disorders.
  • History of recurrent falls (> 2 in the prior year).
  • Grade 3 or greater neuropathy.

Eligibility last updated 5/2/22.  Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Ricardo Parrondo, M.D.

Closed for enrollment

Contact information:

Adam Perlman M.D., M.P.H.

(904) 953-0951

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions